Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases.
Guo HH, Feng CL, Zhang WX, Luo ZG, Zhang HJ, Zhang TT, Ma C, Zhan Y, Li R, Wu S, Abliz Z, Li C, Li XL, Ma XL, Wang LL, Zheng WS, Han YX, Jiang JD.
Guo HH, et al. Among authors: zheng ws.
Nat Commun. 2019 Apr 30;10(1):1981. doi: 10.1038/s41467-019-09852-0.
Nat Commun. 2019.
PMID: 31040273
Free PMC article.